Free Trial

Edwards Lifesciences (EW) Competitors

Edwards Lifesciences logo
$74.80 -1.30 (-1.71%)
Closing price 05/22/2025 03:59 PM Eastern
Extended Trading
$74.72 -0.07 (-0.10%)
As of 05:29 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EW vs. BSX, SYK, MDT, BDX, IDXX, RMD, DXCM, STE, PODD, and BAX

Should you be buying Edwards Lifesciences stock or one of its competitors? The main competitors of Edwards Lifesciences include Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), and Baxter International (BAX). These companies are all part of the "health care equipment" industry.

Edwards Lifesciences vs.

Boston Scientific (NYSE:BSX) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, community ranking, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

Edwards Lifesciences received 272 more outperform votes than Boston Scientific when rated by MarketBeat users. Likewise, 70.77% of users gave Edwards Lifesciences an outperform vote while only 69.96% of users gave Boston Scientific an outperform vote.

CompanyUnderperformOutperform
Boston ScientificOutperform Votes
1069
69.96%
Underperform Votes
459
30.04%
Edwards LifesciencesOutperform Votes
1341
70.77%
Underperform Votes
554
29.23%

89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are held by institutional investors. 0.5% of Boston Scientific shares are held by insiders. Comparatively, 1.3% of Edwards Lifesciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Boston Scientific presently has a consensus price target of $114.87, suggesting a potential upside of 10.01%. Edwards Lifesciences has a consensus price target of $80.20, suggesting a potential upside of 7.22%. Given Boston Scientific's stronger consensus rating and higher possible upside, equities analysts plainly believe Boston Scientific is more favorable than Edwards Lifesciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Boston Scientific
0 Sell rating(s)
0 Hold rating(s)
22 Buy rating(s)
2 Strong Buy rating(s)
3.08
Edwards Lifesciences
1 Sell rating(s)
12 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.42

Edwards Lifesciences has a net margin of 72.93% compared to Boston Scientific's net margin of 11.07%. Edwards Lifesciences' return on equity of 19.40% beat Boston Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Boston Scientific11.07% 17.80% 9.85%
Edwards Lifesciences 72.93%19.40%14.37%

Edwards Lifesciences has lower revenue, but higher earnings than Boston Scientific. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Boston Scientific$17.55B8.80$1.85B$1.3776.22
Edwards Lifesciences$5.52B7.95$4.17B$7.0010.69

Boston Scientific has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500.

In the previous week, Boston Scientific had 12 more articles in the media than Edwards Lifesciences. MarketBeat recorded 49 mentions for Boston Scientific and 37 mentions for Edwards Lifesciences. Boston Scientific's average media sentiment score of 1.28 beat Edwards Lifesciences' score of 1.20 indicating that Boston Scientific is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Boston Scientific
36 Very Positive mention(s)
0 Positive mention(s)
10 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Edwards Lifesciences
24 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive

Summary

Boston Scientific beats Edwards Lifesciences on 10 of the 19 factors compared between the two stocks.

Get Edwards Lifesciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EW vs. The Competition

MetricEdwards LifesciencesSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$44.64B$9.45B$5.33B$19.30B
Dividend YieldN/A1.62%5.21%3.84%
P/E Ratio10.7320.7426.7134.53
Price / Sales7.9561.22386.1334.83
Price / Cash27.0419.6738.2517.51
Price / Book6.755.096.774.69
Net Income$4.17B$284.66M$3.23B$1.02B
7 Day Performance-2.59%-1.18%1.80%-1.74%
1 Month Performance6.03%1.44%11.10%7.50%
1 Year Performance-17.08%-21.91%17.11%4.15%

Edwards Lifesciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EW
Edwards Lifesciences
4.3546 of 5 stars
$74.80
-1.7%
$80.20
+7.2%
-17.1%$44.64B$5.52B10.7317,300Positive News
Analyst Forecast
Insider Trade
BSX
Boston Scientific
4.5703 of 5 stars
$106.61
+0.5%
$114.74
+7.6%
+38.5%$157.72B$17.55B85.2945,000Positive News
Analyst Forecast
Options Volume
SYK
Stryker
4.9208 of 5 stars
$394.63
+0.1%
$427.05
+8.2%
+12.8%$150.63B$23.22B50.8551,000Positive News
Analyst Forecast
MDT
Medtronic
4.866 of 5 stars
$86.94
+0.6%
$96.14
+10.6%
-5.6%$111.50B$33.20B26.4395,000Trending News
Earnings Report
Dividend Increase
Analyst Forecast
Options Volume
BDX
Becton, Dickinson and Company
4.9802 of 5 stars
$177.06
+0.9%
$231.44
+30.7%
-26.6%$50.75B$20.87B29.4177,000Positive News
Analyst Forecast
IDXX
IDEXX Laboratories
3.3869 of 5 stars
$521.68
+0.7%
$536.00
+2.7%
-2.5%$41.95B$3.93B48.8910,800Positive News
Analyst Upgrade
RMD
ResMed
4.1045 of 5 stars
$252.96
+0.5%
$258.83
+2.3%
+12.5%$37.09B$5.02B29.878,160Positive News
Insider Trade
DXCM
DexCom
4.7382 of 5 stars
$86.96
+1.7%
$98.11
+12.8%
-35.0%$34.10B$4.15B60.817,600Positive News
Analyst Forecast
STE
STERIS
4.5553 of 5 stars
$252.31
+0.3%
$264.00
+4.6%
+5.6%$24.79B$5.40B53.5716,000Analyst Upgrade
PODD
Insulet
4.437 of 5 stars
$325.70
+0.3%
$306.53
-5.9%
+77.3%$22.92B$2.20B56.252,600Positive News
Analyst Forecast
BAX
Baxter International
4.6514 of 5 stars
$31.49
-0.5%
$37.25
+18.3%
-11.9%$16.16B$10.77B-24.6060,000Gap Up

Related Companies and Tools


This page (NYSE:EW) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners